Bright Green Corporation BGXX announced that it is set to join the broad-market Russell 3000 Index at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the US market opens on June 26, 2023.
The annual Russell indexes reconstitution captures the 4,000 largest US stocks as of April 28, 2023, ranking them by total market capitalization. Membership in the US all-cap Russell 3000 Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000 Index or small-cap Russell 2000 Index as well as the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.
“We believe that inclusion in the widely referenced Russell U.S. Indexes is another milestone in Bright Green’s progress, which includes our recent DEA approval making us the only publicly traded, federally authorized company in the United States,” stated Seamus McAuley, Bright Green’s CEO. “We look forward to continued progress on our strategic path as we now shift our focus to producing high-quality API and botanical raw material for sale to researchers across the U.S. and internationally, as well as producing API for candidates, and so, inclusion in the Russell Index in the healthcare category is continued demonstration of our progress and of the development of the company and its capabilities.
Photo by Esteban López on Unsplash
Related News
Exclusive: Historic Importation Of THC Into The US Could Reshape Global Cannabis Supply Chain
DEA-Licensed Cannabis Producer Bright Green Closes $3.5M Private Placement
Federally Licensed Company To Grow Cannabis For Research Reveals Its Quarterly Earnings
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.